ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 178,54
0,18%
Dow Jones
44 546,08
-0,37%
DAX
22 513,42
-0,43%
Brent Oil
74,39
0,00%
Bitcoin
97 000,46
-0,61%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Axogen Inc (AXGN)

  7. Axogen Inc (AXGN) Actualités

AXGN

Axogen (AXGN)

Axogen Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AXGN
DateHeureSourceTitreSymboleSociété
11/02/202522h58GlobeNewswire Inc.Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025NASDAQ:AXGNAxogen Inc
03/02/202521h33Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AXGNAxogen Inc
03/02/202514h00GlobeNewswire Inc.Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AXGNAxogen Inc
21/01/202519h20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
10/01/202523h00GlobeNewswire Inc.Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AXGNAxogen Inc
10/01/202514h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
10/01/202514h00GlobeNewswire Inc.Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024NASDAQ:AXGNAxogen Inc
07/01/202500h40Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
07/01/202500h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
14/11/202421h31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AXGNAxogen Inc
07/11/202422h34Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AXGNAxogen Inc
07/11/202422h12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXGNAxogen Inc
07/11/202413h00GlobeNewswire Inc.Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA UpdateNASDAQ:AXGNAxogen Inc
24/10/202413h00GlobeNewswire Inc.Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024NASDAQ:AXGNAxogen Inc
06/09/202413h00GlobeNewswire Inc.Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®NASDAQ:AXGNAxogen Inc
03/09/202413h00GlobeNewswire Inc.Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)NASDAQ:AXGNAxogen Inc
13/08/202422h18GlobeNewswire Inc.CytoSorbents Appoints Peter J. Mariani Chief Financial OfficerNASDAQ:AXGNAxogen Inc
09/08/202422h36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AXGNAxogen Inc
09/08/202422h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
08/08/202413h05GlobeNewswire Inc.Axogen, Inc. Announces New Leadership AppointmentsNASDAQ:AXGNAxogen Inc
08/08/202413h00GlobeNewswire Inc.Axogen, Inc. Reports Second Quarter 2024 Financial ResultsNASDAQ:AXGNAxogen Inc
23/07/202413h00GlobeNewswire Inc.Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024NASDAQ:AXGNAxogen Inc
01/07/202413h00GlobeNewswire Inc.Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:AXGNAxogen Inc
24/06/202413h00GlobeNewswire Inc.Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™NASDAQ:AXGNAxogen Inc
28/05/202422h30GlobeNewswire Inc.Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in VandaliaNASDAQ:AXGNAxogen Inc
16/05/202413h00GlobeNewswire Inc.Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®NASDAQ:AXGNAxogen Inc
14/05/202413h00GlobeNewswire Inc.Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads ConferenceNASDAQ:AXGNAxogen Inc
02/05/202413h00GlobeNewswire Inc.Axogen, Inc Reports First Quarter 2024 Financial ResultsNASDAQ:AXGNAxogen Inc
29/04/202422h50GlobeNewswire Inc.Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™NASDAQ:AXGNAxogen Inc
16/04/202413h00GlobeNewswire Inc.Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024NASDAQ:AXGNAxogen Inc
 Showing the most relevant articles for your search:NASDAQ:AXGN

Dernières Valeurs Consultées

EU
AF
Air FranceKLM
EU
BNP
BNP Paribas
EU
RNO
Renault
NASDAQ
GOOGL
Alphabet
EU
EN
Bouygues
EU
CAP
Capgemini
COIN
XRPUSD
Ripple
EU
VIV
Vivendi
NASDAQ
AAPL
Apple
EU
DG
Vinci
EU
CS
Axa
EU
SGO
Cie de SaintGobain
NYSE
MCD
McDonalds
EU
LR
Legrand
SPI
SP500
S&P 500
EU
ORA
Orange
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces